Loading…
This event has ended. Visit the official site or create your own event on Sched.

View analytic
Tuesday, June 28 • 10:45am - 11:45am
#228: Increase Value of Clinical Trials Through Impactful Branding

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Component Type: Workshop
Level: Intermediate

This session will offer participants an exciting opportunity to participate in an agency-style strategic brainstorm session designed to help clinical teams improve the value of their study brands by developing a stronger and more purposeful connection to the brand, key study objectives, and various stakeholders.

**Due to session format, seating will be limited to 50 participants and available on a first come, first served basis. Once all seats are occupied, DIA will be required to close the session, and no more participants will be admitted. Interested attendees are encouraged to arrive early in order to ensure seating.

Learning Objectives

Demonstrate strategic tools that can lead to more meaningful communications for internal and external stakeholders.

Chair

Neil Weisman

Speaker

Facilitator
Robert Klein

Facilitator
Marie Eckerd



Chair
avatar for Neil Weisman

Neil Weisman

Executive Vice President and General Manager, Continuum Clinical
Neil Weisman, EVP and General Manager of Continuum Clinical, helps pharmaceutical and biotech companies bring new therapies to market faster and more efficiently by solving critical communication challenges that impact the clinical development process. With more than 15 years of experience, Neil leads the strategic direction for Continuum Clinical clients and oversees a global team of dedicated healthcare marketers, clinical trial experts, and... Read More →

Speakers
avatar for Marie Eckerd

Marie Eckerd

Global Feasibility and Recruitment Partner, AstraZeneca
Marie Eckerd is currently a Feasibility and Recruitment Partner at Astra Zeneca. She has lead large global programs through submission across various therapy areas. Previous to AstraZeneca, Marie held leadership positions in Project Management and Data Management with the former Wyeth-Ayerst and IBEX Technologies. Recently, she presented at various conferences to highlight work streams that bridged feasibility, data analytics and patient-centered... Read More →
avatar for Robert Klein

Robert Klein

Chief Strategy Officer, Continuum Clinical
Bob Klein, Chief Strategy Officer of Blue Chip Marketing Worldwide and Continuum Clinical, is dedicated to helping pharmaceutical and biotech companies unearth insights that accelerate clinical trail enrollment and retention. With more than 30 years of experience, Bob is responsible for leveraging the agency’s proprietary D3 strategic planning process and full-service primary research capabilities to the maximum benefit of our clients.


Tuesday June 28, 2016 10:45am - 11:45am
Exhibit Hall A Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA